Improving Management of Patients at High Risk for Osteoporotic Fractures (0000-038)

Improving Management of Patients at High Risk for Osteoporotic Fractures

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00139438

Enrollment

4266

Registered

2005-08-31

Start date

2004-09-30

Completion date

2005-06-30

Last updated

2016-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporosis

Brief summary

The purpose of this study is to assess the impact of disease management interventions on percent receiving a bone densitometry test and percent appropriately prescribed a medication for osteoporosis.

Interventions

BEHAVIORALDisease Management Assessment

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

45 Years to No maximum

Healthy volunteers

Inclusion criteria

* Members of the Horizon Blue Cross Blue Shield of New Jersey who are at risk for osteoporosis based on age (women age 65 or older, men and women age 45 or older who have a history of fragility fracture or have a history of taking oral glucocorticoids over 3 months).

Exclusion criteria

* Individuals who are not members of Horizon Blue Cross Blue Shield of New Jersey and who otherwise do not meet the inclusion criteria.

Design outcomes

Primary

Measure	Time frame
A composite measure of bone mineral density (BMD) testing and/or osteoporosis medications prescriptions.	—

Secondary

Measure	Time frame
BMD testing, osteoporosis medication prescriptions, fracture	—

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026